Association of Mu opioid receptor (A118G) and BDNF (G196A) polymorphisms with rehabilitation-induced cortical inhibition and analgesic response in chronic osteoarthritis pain

• Fernanda de Toledo Gonçalves ^[1] ; Kevin Pacheco-Barrios ^[2] ; Ingrid Rebello-Sanchez ^[2] ; Luis Castelo-Branco ^[2] ; Paulo S. de Melo ^[2] ; Joao Parente ^[2] ; Alejandra Cardenas-Rojas ^[2] ; Isabela Firigato ^[1] ; Anne Victorio Pessotto ^[1] ; Marta Imamura ^[1] ; Marcel Simis ^[1] ; Linamara Battistella ^[1] ; Felipe Fregni ^[2]
  1. [1] Universidade de São Paulo

     Universidade de São Paulo

     Brasil

     
  2. [2] Harvard Medical School

     Harvard Medical School

     City of Boston, Estados Unidos

     
• Localización: International journal of clinical and health psychology, ISSN 1697-2600, Vol. 23, Nº. 1, 2023, págs. 51-60
• Idioma: inglés
• DOI: 10.1016/j.ijchp.2022.100330
• Enlaces
  • Texto completo
• Resumen

  • Background/objective Chronic pain due to osteoarthritis (OA) is a prevalent cause of global disability. New biomarkers are needed to improve treatment allocation, and genetic polymorphisms are promising candidates.

    Method We aimed to assess the association of OPRM1 (A118G and C17T) and brain-derived neurotrophic factor (BDNF [G196A]) polymorphisms with pain-related outcomes and motor cortex excitability metrics (measured by transcranial magnetic stimulation) in 113 knee OA patients with chronic pain. We performed adjusted multivariate regression analyses to compare carriers versus non-carriers in terms of clinical and neurophysiological characteristics at baseline, and treatment response (pain reduction and increased cortical inhibitory tonus) after rehabilitation.

    Results Compared to non-carriers, participants with polymorphisms on both OPRM1 (A118G) and BDNF (G196A) genes were less likely to improve pain after rehabilitation (85 and 72% fewer odds of improvement, respectively). Likewise, both carriers of OPRM1 polymorphisms (A118G and C17T) were also less likely to improve cortical inhibition (short intracortical inhibition [SICI], and intracortical facilitation [ICF], respectively). While pain and cortical inhibition improvement did not correlate in the total sample, the presence of OPRM1 (A118G) and BDNF (G196A) polymorphisms moderated this relationship.

    Conclusions These results underscore the promising role of combining genetic and neurophysiological markers to endotype the treatment response in this population.

• Referencias bibliográficas
  • Bennell, K. L., Hunter, D. J., & Hinman, R. S. (2012). Management of osteoarthritis of the knee. Bmj, 345, e4934. https://doi.org/10.1136/bmj.e4934.
  • Berger, C., M€uller-Godeffroy, J., Marx, I., Reis, O., Buchmann, J., & D€uck, A. (2018). Methylphenidate promotes the interaction between...
  • Blyth, F. M., Briggs, A. M., Schneider, C. H., Hoy, D. G., & March, L. M. (2019). The global burden of musculoskeletal painwhere to from...
  • Bobeck, E. N., Chen, Q., Morgan, M. M., & Ingram, S. L. (2014). Contribution of adenylyl cyclase modulation of preand postsynaptic GABA...
  • Candido Santos, L., Gushken, F., Gadotti, G. M., Dias, B. F., Marinelli Pedrini, S., Barreto, M., . . . Fregni, F. (2020). Intracortical inhibition...
  • Cardenas-Rojas, A., Pacheco-Barrios, K., Giannoni-Luza, S., Rivera-Torrejon, O., & Fregni, F. (2020). Noninvasive brain stimulation combined...
  • Cash, R. F. H., Udupa, K., Gunraj, C. A., Mazzella, F., Daskalakis, Z. J., Wong, A. H. C., & Chen, R. (2021). Influence of BDNF Val66Met...
  • Caumo, W., Deitos, A., Carvalho, S., Leite, J., Carvalho, F., Dussan-Sarria, J. A., & Fregni, F. (2016). Motor cortex excitability and...
  • Courtney, C. A., O’Hearn, M. A., & Hornby, T. G. (2012). Neuromuscular function in painful knee osteoarthritis. Current Pain and Headache...
  • Dai, W., Pi, Y.-L., Ni, Z., Tan, X.-Y., Zhang, J., & Wu, Y. (2016). Maintenance of balance between motor cortical excitation and inhibition...
  • Demirtas-Tatlidede, A., Alonso-Alonso, M., Shetty, R. P., Ronen, I., Pascual-Leone, A., & Fregni, F. (2015). Long-term effects of contralesional...
  • Di Lazzaro, V., Pellegrino, G., Di Pino, G., Corbetto, M., Ranieri, F., Brunelli, N., & Capone, F. (2015). Val66Met BDNF gene polymorphism...
  • Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., & Ader, D. N. (2008). Interpreting the clinical...
  • Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., & Weinberger, D. R. (2003). The BDNF val66met...
  • Ferguson, B. R., & Gao, W. J. (2018). PV interneurons: critical regulators of E/I balance for prefrontal cortex-dependent behavior and...
  • Foulkes, T., & Wood, J. N. (2008). Pain genes. Plos Genetics, 4,(7) e1000086. https://doi.org/10.1371/journal.pgen.1000086.
  • Fregni, F., El-Hagrassy, M. M., Pacheco-Barrios, K., Carvalho, S., Leite, J., Simis, M., & Venkatasubramanian, G. (2021). Evidence-based...
  • Generaal, E., Milaneschi, Y., Jansen, R., Elzinga, B. M., Dekker, J., & Penninx, B. W. (2016). The brain-derived neurotrophic factor...
  • Guler, M. A., Celik, O. F., & Ayhan, F. F. (2020). The important role of central sensitization in chronic musculoskeletal pain seen in...
  • Haas, L., Portela, L. V., B€ohmer, A. E., Oses, J. P., & Lara, D. R. (2010). Increased plasma levels of brain derived neurotrophic factor...
  • Hallett, M. (2007). Transcranial magnetic stimulation: a primer. Neuron, 55(2), 187–199. https://doi.org/10.1016/j.neuron.2007.06.026.
  • Hempstead, B. L. (2015). Brain-derived neurotrophic factor: three ligands, many actions. Transactions of the American Clinical and Climatological...
  • Hollins, M., Bryen, C. P., & Taylor, D. (2020). Effects of chronic pain history on perceptual and cognitive inhibition. Experimental...
  • Kittelson, A. J., Thomas, A. C., Kluger, B. M., & Stevens-Lapsley, J. E. (2014). Corticospinal and intracortical excitability of the...
  • Lee, M., Kim, S. E., Kim, W. S., Lee, J., Yoo, H. K., Park, K.-D., & Lee, H. W. (2013). Interaction of motor training and intermittent...
  • Lever, I. J., Bradbury, E. J., Cunningham, J. R., Adelson, D. W., Jones, M. G., McMahon, S. B., & Malcangio, M. (2001). Brainderived...
  • Lima, L. V., Abner, T. S. S., & Sluka, K. A. (2017). Does exercise increase or decrease pain? Central mechanisms underlying these two...
  • Mague, S. D., & Blendy, J. A. (2010). OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug...
  • Malcolm, M. P., Triggs, W. J., Light, K. E., Shechtman, O., Khandekar, G., & Rothi, L. J. G. (2006). Reliability of motor cortex transcranial...
  • McDonnell, M. N., Orekhov, Y., & Ziemann, U. (2006). The role of GABAB receptors in intracortical inhibition in the human motor cortex....
  • Menzler, K., Hermsen, A., Balkenhol, K., Duddek, C., Bugiel, H., Bauer, S., & Rosenow, F. (2014). A common SCN1A splice-site polymorphism...
  • Merighi, A. (2018). The histology, physiology, neurochemistry and circuitry of the substantia gelatinosa Rolandi (lamina II) in mammalian...
  • Miller, N. R., Yasen, A. L., Maynard, L. F., Chou, L. S., Howell, D. R., & Christie, A. D. (2014). Acute and longitudinal changes in...
  • Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic...
  • Moll, G. H., Heinrich, H., & Rothenberger, A. (2003). Methylphenidate and intracortical excitability: opposite effects in healthy subjects...
  • Nijs, J., Meeus, M., Versijpt, J., Moens, M., Bos, I., Knaepen, K., & Meeusen, R. (2015). Brain-derived neurotrophic factor as a driving...
  • Notaras, M., Hill, R., & van den Buuse, M. (2015). The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility:...
  • Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., & Yamakawa, K. (2007). Nav1.1 localizes to axons of parvalbumin-positive...
  • Pacheco-Barrios, K., Meng, X., & Fregni, F. (2020). Neuromodulation techniques in phantom limb pain: A systematic review and metaanalysis...
  • Peciña, M., Love, T., Stohler, C. S., Goldman, D., & Zubieta, J. K. (2015). Effects of the Mu opioid receptor polymorphism (OPRM1 A118G)...
  • Rossini, P. M., Burke, D., Chen, R., Cohen, L. G., Daskalakis, Z., Di Iorio, R., & George, M. S. (2015). Non-invasive electrical and...
  • Sanger, F., Nicklen, S., & Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A, 74(12),...
  • Schwenkreis, P., Janssen, F., Rommel, O., Pleger, B., Volker, B., Hosbach, I., & Tegenthoff, M. (2003). Bilateral motor cortex disinhibition...
  • Simis, M., Imamura, M., de Melo, P., Marduy, A., Battistella, L., & Fregni, F. (2021). Deficit of inhibition as a marker of neuroplasticity...
  • Simis, M., Imamura, M., de Melo, P. S., Marduy, A., Pacheco-Barrios, K., Teixeira, P. E. P., & Fregni, F. (2021). Increased motor cortex...
  • Sluka, K. A., O’Donnell, J. M., Danielson, J., & Rasmussen, L. A. (2013). Regular physical activity prevents development of chronic...
  • Tan, E.-C., Tan, C.-H., Karupathivan, U., & Yap, E. P. H. (2003). Mu opioid receptor gene polymorphisms and heroin dependence in Asian...
  • Turner, M. N., Hernandez, D. O., Cade, W., Emerson, C. P., Reynolds, J. M., & Best, T. M. (2020). The role of resistance training dosing...
  • Vossen, H., Kenis, G., Rutten, B., van Os, J., Hermens, H., & Lousberg, R. (2010). The genetic influence on the cortical processing of...
  • Wang, Y. J., Huang, P., Ung, A., Blendy, J. A., & Liu-Chen, L. Y. (2012). Reduced expression of the m opioid receptor in some, but not...
  • Willett, M. J., Siebertz, M., Petzke, F., Erlenwein, J., Rushton, A., Soldini, E., & Falla, D. (2020). The extent of pain is associated...
  • Xie, S. H., Wang, Q., Wang, L. Q., Wang, L., Song, K. P., & He, C. Q. (2021). Effect of internet-based rehabilitation programs on improvement...
  • Yue, L., Ma, L. Y., Cui, S., Liu, F. Y., Yi, M., & Wan, Y. (2017). Brainderived neurotrophic factor in the infralimbic cortex alleviates...
  • Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadee, W. (2005). Allelic expression imbalance of human mu opioid receptor (OPRM1)...
  • Ziemann, U. (2013). Pharmaco-transcranial magnetic stimulation studies of motor excitability. Handbook of Clinical Neurology, 116, 387–397....
  • Ziemann, U., Tergau, F., Wischer, S., Hildebrandt, J., & Paulus, W. (1998). Pharmacological control of facilitatory I-wave interaction...
  • Zorina-Lichtenwalter, K., Meloto, C. B., Khoury, S., & Diatchenko, L. (2016). Genetic predictors of human chronic pain conditions. Neuroscience,...